US approves Pfizer vaccine as millions of doses begin shipping

Published December 12, 2020
This file illustration photo taken on November 17 shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Pfizer. — AFP
This file illustration photo taken on November 17 shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Pfizer. — AFP

The United States green-lighted the Pfizer-BioNTech Covid-19 vaccine late on Friday, paving the way for millions of vulnerable people to receive their shots in the world's hardest-hit country.

President Donald Trump immediately released a video on Twitter, where he hailed the news as a “medical miracle” and said the first immunisations would take place “in less than 24 hours”.

It comes as infections across America soar as never before, with the grim milestone of 300,000 confirmed deaths fast approaching.

The US is now the sixth country to approve the two-dose regimen, after Britain, Bahrain, Canada, Saudi Arabia and Mexico.

The move came earlier than expected and capped a day of drama after it was widely reported that the White House had threatened to fire Food and Drug Administration chief Stephen Hahn if he did not grant emergency approval Friday.

Trump's intervention reinserts politics into the scientific process, which some experts have said could undermine vaccine confidence.

The US is seeking to inoculate 20 million people this month alone, with long-term care facility residents and health care workers at the front of the line.

The government also said Friday that it is buying 100m more doses of the Moderna vaccine candidate, amid reports the government passed on the opportunity to secure more supply of the Pfizer jab. The purchase brings its total supply of Moderna doses to 200m, enough to immunise 100m people with the two-shot regimen that could be approved as early as next week.

Both frontrunners are based on mRNA (messenger ribonucleic acid), a major victory for a technology that had never previously been proven.

Two other vaccine candidates stumbled Friday: France's Sanofi and Britain's GSK said their vaccine would not be ready until the end of 2021.

And in Australia, the development of a vaccine at The University of Queensland was abandoned Friday after clinical trials produced a false positive HIV result among subjects involved in early testing.

Sputnik mix

The mixed news on the vaccine front comes as infections accelerated fast in North America and parts of Africa but started to stabilise in Europe and drop in Asia and the Middle East.

Around the world, more than 1.58m lives have been lost to Covid-19 since it emerged in China a year ago, according to an AFP tally from official sources.

Brazil on Friday crossed 180,000 deaths, despite President Jair Bolsonaro's insistence the crisis was at the “tail end.” But across the Pacific Ocean, New Zealand, which has been praised for its handling of the virus, took its first tentative steps towards reopening its borders — with the tiny Cook Islands.

Countries that have approved the Pfizer-BioNTech jab meanwhile were preparing for roll-out, as the World Health Organisation warned of a potentially grim Christmas season.

Following Britain's lead, the first vaccine shipments to 14 sites across Canada are scheduled to arrive on Monday with people receiving shots a day or two later.

Israel, which accepted its first shipment of the Pfizer vaccine on Wednesday, is targeting a rollout on December 27.

And Hong Kong said Friday it had struck deals for two vaccines — one from Pfizer and the other from Beijing-based Sinovac — with plans to launch a campaign in early 2021.

A new combined approach is also being tested by AstraZeneca, whose Russian operation said it would mix its shot with the locally-made Sputnik V vaccine in clinical trials.

Russia and China have already begun inoculation efforts with domestically produced vaccines that have seen less rigorous vetting.

EU countries are eagerly awaiting clearance on the Pfizer and Moderna vaccines, in late December and early January respectively.

Carbon down

As Europe's surge eases off slightly, France is planning to lift a six-week-long lockdown from Tuesday but impose a curfew from 8pm, including on New Year's Eve.

Greece also announced new plans Friday to slash quarantine time for incoming travelers and reopen churches for Christmas.

But Switzerland, which is seeing a sharp resurgence in cases, announced a 7pm curfew for shops, restaurants and bars.

While lockdowns have brought economic pain, boredom and myriad other woes, the effect on the environment has been more positive.

Carbon emissions fell a record seven per cent in 2020 as countries imposed lockdowns, according to the Global Carbon Project.

Opinion

Let women be, control the man
11 Apr 2021

Let women be, control the man

Men need to be educated and then read the riot act. The enforcement of the law must be merciless in such cases.
Twixt torch & tray
11 Apr 2021

Twixt torch & tray

Some may say that the lawyers’ indignation is not without merit.
Behaviour bond
10 Apr 2021

Behaviour bond

States have turned the imitation of repressive laws into an art form...

Editorial

11 Apr 2021

Dissension within PTI

WITH the dust from the PDM’s implosion still not fully settled, the PTI is now faced with growing dissension from...
11 Apr 2021

Power to arrest

A SUPREME Court verdict announced on Thursday spelled out what might be considered a self-evident truth in any...
11 Apr 2021

Unequal vaccine distribution

IT is in times of crisis that we often see the best — or worst — of humanity. In this regard, the pandemic has...
10 Apr 2021

Greater tax burden

THE FBR’s tax target of Rs6tr for the next year under the IMF-mandated fiscal adjustment policies will increase ...
UK travel ban
Updated 10 Apr 2021

UK travel ban

Pakistan continued to allow passengers to arrive without quarantine requirements.
10 Apr 2021

IS in Mozambique

IT was not too long ago when the dreaded shock troops of the self-declared Islamic State group were rampaging ...